0 Shares

Cochlear receives FDA approval on new hearing device that combines best-in-class hearing performance with a simple, discreet design

Cochlear Kanso - Woman Wearing - 2

Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, announces today it has received U.S. Food and Drug Administration (FDA) approval for its newest innovative hearing loss solution, Kanso.

The Kanso Sound Processor provides a distinct new way for cochlear implant users to hear. Unlike most hearing aids and current cochlear implant sound processors that are worn on the ear, Kanso is a small, off-the-ear hearing device that provides a more discreet hearing solution and delivers the same hearing experience as a behind-the-ear sound processor.

The name Kanso is a Japanese word for ‘simplicity,’ and it was selected in recognition of Kanso’s all-in-one design. The Kanso Sound Processor features a single on/off button with no cables so it is easy to use. It is worn on the user’s head with nothing behind the ear, adding greater comfort for those with glasses, and it can be easily hidden under or blended within a user’s hair.

“Our recipients are at the heart of everything we do at Cochlear, and delivering Kanso to the market is in direct response to us listening to our customers,” said Tony Manna, President of Cochlear North America. “Through customer feedback, we identified the need for a new solution that provides the advanced technology and hearing performance of our latest cochlear implant sound processor, which is worn behind the ear, in an easy and discreet design with access to wireless and water accessories, all without losing the high-quality hearing experience our customers expect from our products. Kanso offers all that and much more.”

Kanso is discreet, smart and simple. As the smallest, lightest off-the-ear sound processor on the market and the only one featuring dual microphones, Kanso provides the user discretion, enhanced comfort as well as the most advanced hearing technology.2, 3

Commercial availability for Kanso is expected this fall in the United States and Canada for those who are looking to receive a cochlear implant.

For more information on Kanso, click here or visit cochlear.com/us/kanso.

  1. Jones, Marian, Mauger, Stefan. Cochlear® Clinical Investigation Report. Acceptance of the CP950/KANSO sound processor with experienced CP810/CP900 series BTE sound processor participants. Version 1.0. Clinical Investigation Plan Number CLTD5591 v.5. Windchill No. 582225. CIR D1072418. Aug 12, 2016.
  2. Cochlear Limited. CP950 Kanso Sound Processor User Guide. Data on file, July 2016.
  3. MED-EL Medical Electronics. RONDO User Manual. Last accessed July 2016. Available at: http://www.medel.com/int/rondo.
Renee Oehlerking
Renee Oehlerking is the Public Relations Manager at Cochlear Americas where she is responsible for the region’s public relations and consumer marketing social media. Renee enjoys uncovering, telling and showcasing the inspiring stories of hearing implant recipients. As a recent transplant to Denver, Colorado, Renee enjoys exploring all that the state has to offer outdoors.